EuroEyes reports record revenue, declares final dividend

EuroEyes International Eye Clinic (HKEX:1846) announced record revenue of HK$715.7 million for the year ended December 31, 2024, a slight increase from HK$714.3 million the previous year, driven by lens exchange surgeries. The company's board has recommended a final dividend of HKD0.0297 per share, or approximately HK$9,524,968, subject to shareholder approval on June 6, 2025, with payment scheduled for June 27, 2025, following book closure from June 12-13.